Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
from NDTV News - Topstories https://ift.tt/3nX8fwP
Subscribe to:
Post Comments (Atom)
Govt weighing steps to check current account deficit: Piyush Goyal
from Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/W6DlEx2
-
China has emerged as a significant player in AI foundation models with DeepSeek, creating powerful AI models at lower costs than the West. T...
-
Nigeria's President Buhari on Sunday denied claims that he had died and been replaced by a Sudanese impostor, breaking his silence on a ...
-
Meng Wanzhou, the high-profile top executive of telecom giant Huawei who was detained in Canada for over three years, received a hero's ...
No comments:
Post a Comment